Ingevity Corp Files 8-K on Director/Officer Changes

TL;DR

Ingevity's board is shuffling, expect news on exec pay soon.

AI Summary

On March 10, 2025, Ingevity Corporation filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing indicates a departure of a director and potentially new appointments or changes to officer compensation, though specific names and dollar amounts for these changes are not detailed in this initial summary.

Why It Matters

Changes in a company's board of directors and executive compensation can signal shifts in strategy, governance, or financial outlook, impacting investor confidence.

Risk Assessment

Risk Level: low — This filing is procedural, reporting standard corporate governance changes without immediate financial implications.

Key Players & Entities

• Ingevity Corporation (company) — Registrant
• March 10, 2025 (date) — Date of Report

FAQ

From the Filing

0001140361-25-007884.txt : 20250310 0001140361-25-007884.hdr.sgml : 20250310 20250310164812 ACCESSION NUMBER: 0001140361-25-007884 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20250310 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250310 DATE AS OF CHANGE: 20250310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ingevity Corp CENTRAL INDEX KEY: 0001653477 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 474027764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37586 FILM NUMBER: 25724472 BUSINESS ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 BUSINESS PHONE: 8437402300 MAIL ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 8-K 1 ef20045156_8k.htm 8-K false 0001653477 0001653477 2025-03-10 2025-03-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 March 10, 2025 Date of Report (date of earliest event reported) INGEVITY CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37586 47-4027764 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 4920 O'Hear Avenue Suite 400 North Charleston South Carolina 29405 (Address of principal executive offices) (Zip code) Registrant’s telephone number, including area code: 843 - 740-2300 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☒ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock ($0.01 par value) NGVT NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐ Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act  ☐   ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On March 10, 2025, Ingevity Corporation (“Ingevity”) announced that its Board of Directors (the “Board”) has appointed David H. Li as President and Chief Executive Officer of Ingevity, effective April 7, 2025 (the “Effective Date”). Mr. Li is also expected to join the Board following Ingevity’s 2025 annual meeting of the stockholders. In connection with Mr. Li’s appointment, Luis Fernandez-Moreno will step down as interim President and Chief Executive Officer of Ingevity as of th